{
  "type": "add_node",
  "timestamp": "2025-08-15T02:28:38",
  "processed": false,
  "inputs": {
    "source_article_id": "SUNK4E191",
    "status": "rejected",
    "reject_category": "company",
    "reject_failure_cat": "industry_vertical"
  },
  "details": {
    "llm_topic_proposal_raw": {
      "motivation": "The merger of Vyome Therapeutics with ReShape Lifesciences introduces a new publicly traded entity that could impact investment strategies in the healthcare sector, warranting a dedicated node for analysis.",
      "id": "vyome_holdings",
      "name": "Vyome Holdings",
      "type": "company",
      "level": "main"
    },
    "topic_category": {
      "category": "company",
      "motivation": "Vyome Holdings is a newly formed public company resulting from a merger, fitting the company category."
    },
    "relevance_gate": {
      "should_add": false,
      "reason": "Vyome Holdings is a specific healthcare company, an industry vertical, not a macro driver, tradable asset, or macro policy/regime; it does not meet the criteria for inclusion.",
      "confidence": 0.95,
      "failure_category": "industry_vertical"
    }
  },
  "id": "none"
}